| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908612 | Leukemia Research | 2015 | 6 Pages |
Abstract
Flow cytometry (FCM) has found its application in clinical diagnosis and evaluation of monoclonal gammopathies (MG). Although, research has been mainly focused on multiple myeloma (MM), nowadays FCM becomes to be potential tool in the field of AL amyloidosis. Clonal plasma cells identification and specific phenotype profile detection is important for diagnosis, monitoring and prognosis of AL amyloidosis. Therefore, FCM could be a perspective method for study not only MM but also AL amyloidosis. This review provides an overview and possibilities of FCM application in AL amyloidosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jana Filipova, Lucie Rihova, Pavla Vsianska, Zuzana Kufova, Elena Kryukova, Fedor Kryukov, Roman Hajek,